Pediatrix Medical Group, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 18, 2007
PEDIATRIX MEDICAL GROUP, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|
|
Florida
|
|
001-12111
|
|
65-0271219 |
|
|
|
|
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
1301 Concord Terrace
Sunrise, Florida 33323
(Address of principal executive office)
Registrants telephone number, including area code (954) 384-0175
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On September 18, 2007, Pediatrix Medical Group, Inc. (the Company), certain of the Companys
subsidiaries and affiliates (collectively with the Company, the Borrowers), Bank of America, N.A.
(the Administrative Agent), and each of the lenders signatory thereto entered into a third
amendment (the Amendment No. 3) to that certain credit agreement, dated as of July 30, 2004,
among the Borrowers, the Administrative Agent and each of the lenders signatory thereto, as
previously amended on January 11, 2005 and on March 10, 2005 (the Credit Agreement).
Pursuant to Amendment No. 3, the parties have agreed to modify Section 7.06 pertaining to
permitted acquisitions by the Borrowers. In particular, the aggregate amount of acquisition costs
and earnout payments (for any acquisition exceeding $5,000,000) that the Borrowers may incur in
connection with acquisitions in any fiscal year has been increased to $200,000,000 from
$100,000,000. In addition, Section 7.06 has also been revised to provide that any business which
upon acquisition constitutes a Material Subsidiary (as such term is defined in the Credit
Agreement) need not become a Borrower under the Credit Agreement until 30 days after its
acquisition.
The foregoing description of the Amendment No. 3 does not purport to be complete and is
qualified in its entirety by reference to the full text of such Amendment No. 3, a copy of which is
filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference
thereto.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits.
10.1 Amendment No. 3, dated September 18, 2007, to the Credit Agreement.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
PEDIATRIX MEDICAL GROUP, INC.
|
|
Date: September 18, 2007 |
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Chief Financial Officer |
|
|
3
EXHIBIT INDEX
|
|
|
Exhibit No. |
|
Description |
|
|
|
10.1
|
|
Amendment No. 3, dated September 18, 2007, to the Credit Agreement. |
4
EX-10.1 Amendment No. 3 to Credit Agreement
Exhibit 10.1
Execution Version
AMENDMENT NO. 3 TO CREDIT AGREEMENT
This Amendment No. 3 to Credit Agreement dated as of September 18, 2007 (this Amendment), is
made by and among PEDIATRIX MEDICAL GROUP, INC., a Florida corporation (the Company), certain of
its subsidiaries and affiliates (together with the Company, collectively, the Borrowers), BANK OF
AMERICA, N.A. in its capacity as administrative agent (in such capacity, the Administrative
Agent) under the Credit Agreement described below, and each of the Lenders signatory hereto.
RECITALS:
A. The Borrowers, the Administrative Agent and the lenders from time to time party thereto
(the Lenders) have entered into that certain Credit Agreement dated as of July 30, 2004 (as
amended by that certain Amendment No. 1 to Credit Agreement dated January 11, 2005 and that certain
Amendment No. 2 to Credit Agreement dated March 10, 2005, the Credit Agreement), pursuant to
which the Lenders have made available to the Borrowers a revolving credit facility. Capitalized
terms used in this Amendment not otherwise defined herein shall have the definitions given thereto
in the Credit Agreement.
B. The Borrowers have requested to amend the Credit Agreement as set forth below and the
Administrative Agent and the Lenders signatory hereto are willing to effect such amendment on the
terms and conditions set forth herein.
In furtherance of the foregoing and for valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:
1. Amendment to Credit Agreement. Subject to the terms and conditions set forth herein,
Section 7.06 of the Credit Agreement is hereby deleted in its entirety and the following is
inserted in lieu thereof:
7.06 Acquisitions. Enter into any Acquisition Agreement, or take any action to solicit
the tender of securities or proxies in respect thereof in order to effect any Acquisition,
unless either (a) the aggregate amount of the Costs of Acquisition and Earnout Payments with
respect to such Acquisition does not exceed $5,000,000, or (b) each of the following
conditions is satisfied: (i) the Person to be (or whose assets are to be) acquired does not
oppose such Acquisition (other than in the case of an Acquisition pursuant to a Holder
Purchase Grant) and has Permitted Acquisition EBITDA for the most recently ended
twelve-month period of not less than $1, (ii) the line or lines of business of the Person to
be acquired are substantially the same as one or more line or lines of business conducted by
the Company and its Subsidiaries, (iii) the operations of the Person to be (or whose assets
are to be) acquired are primarily in the United States or its territories, (iv) no Default
shall have occurred and be continuing either immediately prior to or immediately after
giving effect to such Acquisition and the Company shall have furnished to the Administrative
Agent a Compliance Certificate prepared on an
1
historical pro forma basis as of the most recent date for which financial statements
have been furnished pursuant to Section 4.01 or Section 6.01(a) or
(b) giving effect to such Acquisition, which certificate shall demonstrate that no
Default would exist immediately after giving effect thereto, (v) the Person acquired shall
be a wholly-owned Subsidiary, or be merged into a Borrower, immediately upon consummation of
the Acquisition (or if assets are being acquired, the acquiror shall be a wholly-owned
Subsidiary or a Borrower), (vi) after giving effect to such Acquisition, the aggregate Costs
of Acquisition and Earnout Payments incurred in any fiscal year of the Company (on a
noncumulative basis, with the effect that amounts not incurred in any fiscal year may not be
carried forward to a subsequent period) shall not exceed $200,000,000, of which not more
than $20,000,000 shall be in connection with an Acquisition of a Person (or the assets of a
Person) whose operations are primarily in a territory of the United States, and (vii) after
giving effect to such Acquisition, the aggregate Costs of Acquisition and Earnout Payments
incurred since the Closing Date in connection with Acquisitions of Persons (or the assets of
Persons) whose operations are primarily in one or more territories of the United States
shall not exceed $50,000,000.
2. Effectiveness; Conditions Precedent. The effectiveness of this Amendment is subject
to the satisfaction of the following conditions precedent:
(a) the Administrative Agent shall have received an original or facsimile (promptly
followed by originals) executed counterpart of this Amendment, duly executed by each
Borrower, the Administrative Agent and the Required Lenders; and
(b) all fees and expenses payable to the Administrative Agent and the Lenders
(including the fees and expenses of counsel to the Administrative Agent) invoiced to date
shall have been paid in full.
3. Consent and Continued Enforceability. Each Borrower hereby consents, acknowledges and
agrees to the amendments set forth herein and hereby confirms and ratifies in all respects its
obligations under the Credit Agreement and each other Loan Document (including without limitation
the continuation of such Borrowers payment and performance obligations thereunder upon and after
the effectiveness of this Amendment and the amendments contemplated hereby) and the enforceability
of each such Loan Document against such Borrower in accordance with its terms.
4. Representations and Warranties. In order to induce the Administrative Agent and the
Lenders to enter into this Amendment, each Borrower represents and warrants to the Administrative
Agent and the Lenders as follows:
(a) The representations and warranties made by each Borrower in Article V of
the Credit Agreement and in each of the other Loan Documents to which such Borrower is a
party are true and correct on and as of the date hereof, except to the extent that such
representations and warranties expressly relate to an earlier date, and except that for
purposes of this Section 4, the representations and warranties contained in
subsections (a) and (b) of Section 5.05 of the Credit Agreement shall be deemed to
refer to the most
2
recent statements furnished pursuant to clauses (a) and (b), respectively, of
Section 6.01 of the Credit Agreement;
(b) Other than the matters set forth on Schedule 5.06 of the Credit Agreement,
since the date of the Audited Financial Statements, there has been no event or circumstance,
either individually or in the aggregate, that has had or could reasonably be expected to
have a Material Adverse Effect;
(c) The Persons appearing as Borrowers on the signature pages to this Amendment
constitute all Persons who are required to be Borrowers pursuant to the terms of the Credit
Agreement and the other Loan Documents, including without limitation all Persons who became
Material Subsidiaries or were otherwise required to become Borrowers after the Closing Date,
and each of such Persons has become and remains a party to the Credit Agreement as a
Borrower;
(d) This Amendment has been duly authorized, executed and delivered by the Borrowers
party hereto and constitutes a legal, valid and binding obligation of such parties, except
as may be limited by general principles of equity or by the effect of any applicable
bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors
rights generally; and
(e) No Default or Event of Default has occurred and is continuing.
5. Entire Agreement. This Amendment, together with all the Loan Documents (collectively,
the Relevant Documents), sets forth the entire understanding and agreement of the parties hereto
in relation to the subject matter hereof and supersedes any prior negotiations and agreements among
the parties relating to such subject matter. No promise, condition, representation or warranty,
express or implied, not set forth in the Relevant Documents shall bind any party hereto, and no
such party has relied on any such promise, condition, representation or warranty. Each of the
parties hereto acknowledges that, except as otherwise expressly stated in the Relevant Documents,
no representations, warranties or commitments, express or implied, have been made by any party to
the other. None of the terms or conditions of this Amendment may be changed, modified, waived or
canceled orally or otherwise, except in writing and in accordance with Section 10.01 of the
Credit Agreement.
6. Full Force and Effect of Amendment. Except as hereby specifically amended, the Credit
Agreement and all other Loan Documents are hereby confirmed and ratified in all respects and shall
be and remain in full force and effect according to their respective terms.
7. Counterparts. This Amendment may be executed in any number of counterparts, each of
which shall be deemed an original as against any party whose signature appears thereon, and all of
which shall together constitute one and the same instrument. Delivery of an executed counterpart
of a signature page of this Amendment by telecopy shall be effective as delivery of a manually
executed counterpart of this Amendment.
8. Governing Law. This Amendment shall in all respects be governed by, and construed in
accordance with, the laws of the State of New York applicable to contracts executed
3
and to be performed entirely within such State, and shall be further subject to the provisions
of Sections 10.14 and 10.15 of the Credit Agreement.
9. Enforceability. Should any one or more of the provisions of this Amendment be
determined to be illegal or unenforceable as to one or more of the parties hereto, all other
provisions nevertheless shall remain effective and binding on the parties hereto.
10. References. All references in any of the Loan Documents to the Credit Agreement
shall mean the Credit Agreement, as amended hereby.
11. Successors and Assigns. This Amendment shall be binding upon and inure to the benefit
of the Borrowers, the Administrative Agent and the Lenders, and their respective successors, legal
representatives, and assignees to the extent such assignees are permitted assignees as provided in
Section 10.06 of the Credit Agreement.
[Signature pages follow.]
4
IN WITNESS WHEREOF, the parties hereto have caused this instrument to be made, executed
and delivered by their duly authorized officers as of the day and year first above written.
|
|
|
|
|
|
BORROWERS:
PEDIATRIX MEDICAL GROUP, INC., a Florida Corporation
|
|
|
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Chief Financial Officer |
|
|
|
|
|
|
|
ALASKA NEONATOLOGY ASSOCIATES, INC. |
|
|
ASSOCIATES IN NEONATOLOGY, INC. |
|
|
AUGUSTA NEONATOLOGY ASSOCIATES, P.C. |
|
|
BNA ACQUISITION COMPANY, INC. |
|
|
CENTRAL OKLAHOMA NEONATOLOGY ASSOCIATES, INC. |
|
|
CNA ACQUISITION CORP. |
|
|
FLORIDA REGIONAL NEONATAL ASSOCIATES, INC. |
|
|
FOOTHILL MEDICAL GROUP, INC. |
|
|
FORT WORTH NEONATAL ASSOCIATES BILLING, INC. |
|
|
GNPA ACQUISITION COMPANY, INC. |
|
|
MAGELLA HEALTHCARE CORPORATION |
|
|
MAGELLA HEALTHCARE GROUP, L.P. |
|
|
MAGELLA MEDICAL ASSOCIATES BILLING, INC. |
|
|
MAGELLA MEDICAL ASSOCIATES MIDWEST, P.C. |
|
|
MAGELLA MEDICAL ASSOCIATES OF GEORGIA, P.C. |
|
|
MAGELLA MEDICAL GROUP, INC. |
|
|
MAGELLA NEVADA, LLC |
|
|
MAGELLA TEXAS, LLC |
|
|
|
|
|
|
|
|
|
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Attorney-in-Fact |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
MNPC ACQUISITION COMPANY, INC. |
|
|
MOUNTAIN STATES NEONATOLOGY, INC. |
|
|
NACF ACQUISITION COMPANY, INC. |
|
|
NEONATAL AND PEDIATRIC INTENSIVE
CARE MEDICAL GROUP, INC. |
|
|
NEONATOLOGY ASSOCIATES BILLING, INC. |
|
|
NEONATAL SPECIALISTS, LTD. |
|
|
NSPA ACQUISITION COMPANY, INC. |
|
|
OBSTETRIX ACQUISITION COMPANY OF ARIZONA, INC. |
|
|
OBSTETRIX ACQUISITION COMPANY OF COLORADO, INC. |
|
|
OBSTETRIX MEDICAL GROUP OF ARIZONA, P.C. |
|
|
OBSTETRIX MEDICAL GROUP OF CALIFORNIA, A PROFESSIONAL CORPORATION |
|
|
OBSTETRIX MEDICAL GROUP OF COLORADO, P.C. |
|
|
OBSTETRIX MEDICAL GROUP OF KANSAS AND MISSOURI, P.A. |
|
|
OBSTETRIX MEDICAL GROUP OF PHOENIX, P.C. |
|
|
OBSTETRIX MEDICAL GROUP OF TEXAS BILLING, INC. |
|
|
OBSTETRIX MEDICAL GROUP OF WASHINGTON, INC., P.S. |
|
|
OBSTETRIX MEDICAL GROUP, INC. |
|
|
OZARK NEONATAL ASSOCIATES, INC. |
|
|
PALM BEACH NEO ACQUISITIONS, INC. |
|
|
PASCV ACQUISITION COMPANY, INC. |
|
|
PEDIATRIX ACQUISITION COMPANY OF OHIO, INC. |
|
|
PEDIATRIX ACQUISITION COMPANY OF WASHINGTON, INC. |
|
|
PEDIATRIX FLORIDA LLC |
|
|
|
|
|
|
|
|
|
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Attorney-in-Fact |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
PEDIATRIX MEDICAL GROUP NEONATOLOGY AND PEDIATRIC INTENSIVE CARE SPECIALISTS OF NEW YORK, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF ARKANSAS, P.A. |
|
|
PEDIATRIX MEDICAL GROUP OF CALIFORNIA, A PROFESSIONAL CORPORATION |
|
|
PEDIATRIX MEDICAL GROUP OF COLORADO, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF FLORIDA, INC. |
|
|
PEDIATRIX MEDICAL GROUP OF GEORGIA, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF ILLINOIS, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF INDIANA, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF KANSAS, P.A. |
|
|
PEDIATRIX MEDICAL GROUP OF KENTUCKY, P.S.C. |
|
|
PEDIATRIX MEDICAL GROUP OF LOUISIANA, L.L.C. |
|
|
PEDIATRIX MEDICAL GROUP OF MICHIGAN, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF MISSOURI, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF NEW MEXICO, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF NORTH CAROLINA, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF OHIO CORP. |
|
|
PEDIATRIX MEDICAL GROUP OF OKLAHOMA, P.C. |
|
|
|
|
|
|
|
|
|
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Attorney-in-Fact |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
PEDIATRIX MEDICAL GROUP OF PENNSYLVANIA, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF PUERTO RICO, P.S.C. |
|
|
PEDIATRIX MEDICAL GROUP OF SOUTH CAROLINA, P.A. |
|
|
PEDIATRIX MEDICAL GROUP OF TENNESSEE, P.C. |
|
|
PEDIATRIX MEDICAL GROUP OF TEXAS BILLING, INC. |
|
|
PEDIATRIX MEDICAL GROUP OF WASHINGTON, INC., P.S. |
|
|
PEDIATRIX MEDICAL GROUP, INC., a Utah corporation |
|
|
PEDIATRIX MEDICAL GROUP, P.A. |
|
|
PEDIATRIX MEDICAL GROUP, P.C., a Virginia corporation |
|
|
PEDIATRIX MEDICAL GROUP, P.C., a West Virginia corporation |
|
|
PEDIATRIX MEDICAL MANAGEMENT, L.P. |
|
|
PEDIATRIX MEDICAL SERVICES, INC. |
|
|
PEDIATRIX OF MARYLAND, P.A. |
|
|
PEDIATRIX SCREENING, INC. |
|
|
PEDIATRIX TEXAS I LLC |
|
|
PEDIATRIX VIRGINIA ACQUISITION COMPANY, INC. |
|
|
PERINATAL PEDIATRICS, P.A. PMGSC, P.A. |
|
|
PNA ACQUISITION CO., INC. |
|
|
POKROY MEDICAL GROUP OF NEVADA, LTD. |
|
|
RPNA ACQUISITION COMPANY, INC. |
|
|
SCPMC ACQUISITION CO. |
|
|
SNCA ACQUISITION COMPANY, INC. |
|
|
ST. JOSEPH NEONATOLOGY CONSULTANTS, INC. |
|
|
|
|
|
|
|
|
|
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Attorney-in-Fact |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
TEXAS MATERNAL FETAL MEDICINE BILLING, INC.
|
|
|
TEXAS NEWBORN SERVICES, INC.
|
|
|
TUCSON PERINATAL SERVICES, P.C. |
|
|
|
|
|
|
|
|
|
By: |
/s/ Karl B. Wagner
|
|
|
|
Name: |
Karl B. Wagner |
|
|
|
Title: |
Attorney-in-Fact |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
ADMINISTRATIVE AGENT:
BANK OF AMERICA, N.A., as Administrative Agent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Alysa Trakas
|
|
|
|
Name: |
Alysa Trakas |
|
|
|
Title: |
Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
LENDERS:
BANK OF AMERICA, N.A. as a Lender, L/C Issuer
and Swing Line Lender
|
|
|
By: |
/s/ Alysa Trakas
|
|
|
|
Name: |
Alysa Trakas |
|
|
|
Title: |
Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
HSBC BANK USA, NATIONAL ASSOCIATION
|
|
|
By: |
/s/ Jose M. Cruz
|
|
|
|
Name: |
Jose M. Cruz |
|
|
|
Title: |
Senior Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
SUNTRUST BANK
|
|
|
By: |
/s/ Helen C. Hartz
|
|
|
|
Name: |
Helen C. Hartz |
|
|
|
Title: |
Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
U.S. BANK NATIONAL ASSOCIATION
|
|
|
By: |
/s/ S. Walker Choppin
|
|
|
|
Name: |
S. Walker Choppin |
|
|
|
Title: |
Senior Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
WACHOVIA BANK, N.A.
|
|
|
By: |
/s/ Aly Heimovics
|
|
|
|
Name: |
Aly Heimovics |
|
|
|
Title: |
Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
KEYBANK NATIONAL ASSOCIATION
|
|
|
By: |
/s/ J.T. Taylor
|
|
|
|
Name: |
J.T. Taylor |
|
|
|
Title: |
Senior Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
UBS LOAN FINANCE LLC
|
|
|
By: |
/s/ Mary E. Evans
|
|
|
|
Name: |
Mary E. Evans |
|
|
|
Title: |
Associate Director |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Irja R. Otsa
|
|
|
|
Name: |
Irja R. Otsa |
|
|
|
Title: |
Associate Director |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
THE INTERNATIONAL BANK OF MIAMI, N.A.
|
|
|
By: |
/s/ Panayiotis Ch. Zotos
|
|
|
|
Name: |
Panayiotis Ch. Zotos |
|
|
|
Title: |
Senior Vice President |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages
|
|
|
|
|
|
MERRILL LYNCH BANK USA
|
|
|
By: |
/s/ Louis Alder
|
|
|
|
Name: |
Louis Alder |
|
|
|
Title: |
Director |
|
|
Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages